Together, our results suggest that pharmacological inhibition of IL-6 and leptin as well as the downstream JAK/STAT3 and PI3K/AKT signaling pathways can decrease PLOD2 expression and suppress breast cancer metastasis. Here, PLOD2 is linked to breast carcinoma.